VRC Vaccine Research Studies

Current Vaccine Clinical Studies

We are currently enrolling volunteers for a range of studies. If you are interested in volunteering to participate in a clinical trial, call 866-833-LIFE (866-833-5433), email vaccines@nih.gov, or fill out a confidential Volunteer Questionnaire.

Studies Open to Accrual

VRC 000 (02-I-0127):
Screening Subjects for HIV Vaccine Research Studies

VRC 016 (11-I-0197)
Immune Responses to Two Experimental HIV Vaccines in Healthy Adults

HVTN 505 (09-I-0163):
Phase 2b, randomized, placebo-controlled test-of-concept trial to evaluate the safety and efficacy of a multiclade HIV-1 DNA plasmid vaccine followed by a multiclade HIV-1 recombinant adenoviral vector vaccine in HIV-uninfected, adenovirus type 5 neutralizing antibody negative, circumcised men and male-to-female (MTF) transgender persons, who have sex with men

VRC 500 (11-I-0164):
Screening of Volunteers for Clinical Trials of Investigational Products and Licensed Products Evaluated for Research Purposes

VRC 312 (11-I-0257)
Phase 1, Open-Label, Dose-Escalation Clinical Trial with Experimental Challenge to Evaluate Intravenous Administration of PfSPZ Vaccine in Malaria-Naive Adults

VRC 900 (10-I-0109):
Evaluation of Tissue-Specific Immune Responses in Adults 18 Years of Age and Older

VRC 200 (03-I-0263):
Apheresis Procedures to Obtain Plasma or Peripheral Blood Mononuclear Cells (PBMCs) for Research Studies

back to top